|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burris HR III, Moore MJ, Andersen J, Green
MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo
AM, Tarassoff P, et al: Improvements in survival and clinical
benefit with gemcitabine as first-line therapy for patients with
advanced pancreas cancer: A randomized trial. J Clin Oncol.
15:2403–2413. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shiao MS: Natural products of the
medicinal fungus Ganoderma lucidum: Occurrence, biological
activities, and pharmacological functions. Chem Rec. 3:172–180.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Teng BS, Wang CD, Yang HJ, Wu JS, Zhang D,
Zheng M, Fan ZH, Pan D and Zhou P: A protein tyrosine phosphatase
1B activity inhibitor from the fruiting bodies of Ganoderma
lucidum (Fr.) Karst and its hypoglycemic potency on
streptozotocin-induced type 2 diabetic mice. J Agric Food Chem.
59:6492–6500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pan D, Wang L, Chen C, Hu B and Zhou P:
Isolation and characterization of a hyperbranched proteoglycan from
Ganoderma lucidum for anti-diabetes. Carbohyd Polym.
117:106–114. 2015. View Article : Google Scholar
|
|
7
|
Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H
and Zhou P: Antidiabetic, antihyperlipidemic and antioxidant
activities of a novel proteoglycan from Ganoderma lucidum
fruiting bodies on db/db mice and the possible mechanism. PLoS One.
8:e683322013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Teng BS, Wang CD, Zhang D, Wu JS, Pan D,
Pan LF, Yang HJ and Zhou P: Hypoglycemic effect and mechanism of a
proteoglycan from ganoderma lucidum on
streptozotocin-induced type 2 diabetic rats. Eur Rev Med Pharmacol
Sci. 16:166–175. 2012.PubMed/NCBI
|
|
9
|
Gorrini C, Harris IS and Mak TW:
Modulation of oxidative stress as an anticancer strategy. Nat Rev
Drug Discov. 12:931–947. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, McMillan-Ward E, Kong J, Israels
SJ and Gibson SB: Oxidative stress induces autophagic cell death
independent of apoptosis in transformed and cancer cells. Cell
Death Differ. 15:171–182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khan M, Ding C, Rasul A, Yi F, Li T, Gao
H, Gao R, Zhong L, Zhang K, Fang X and Ma T: Isoalantolactone
induces reactive oxygen species mediated apoptosis in pancreatic
carcinoma PANC-1 cells. Int J Biol Sci. 8:533–547. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schumacker PT: Reactive oxygen species in
cancer cells: Live by the sword, die by the sword. Cancer Cell.
10:175–176. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li PF, Dietz R and von Harsdorf R: p53
regulates mitochondrial membrane potential through reactive oxygen
species and induces cytochrome c-independent apoptosis blocked by
Bcl-2. EMBO J. 18:6027–6036. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Vries HE, Witte M, Hondius D,
Rozemuller AJ, Drukarch B, Hoozemans J and van Horssen J:
Nrf2-induced antioxidant protection: A promising target to
counteract ROS-mediated damage in neurodegenerative disease? Free
Radic Biol Med. 45:1375–1383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hur J, Sullivan KA, Schuyler AD, Hong Y,
Pande M, States DJ, Jagadish HV and Feldman EL: Literature-based
discovery of diabetes- and ROS-related targets. BMC Med Genomics.
3:492010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pelicano H, Carney D and Huang P: ROS
stress in cancer cells and therapeutic implications. Drug Resist
Updat. 7:97–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liochev SI: Reactive oxygen species and
the free radical theory of aging. Free Radic Biol Med. 60:1–4.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mizushima N: Autophagy: Process and
function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo JY, Chen HY, Mathew R, Fan J,
Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM,
Karantza V, et al: Activated Ras requires autophagy to maintain
oxidative metabolism and tumorigenesis. Genes Dev. 25:460–470.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang S, Wang X, Contino G, Liesa M, Sahin
E, Ying H, Bause A, Li Y, Stommel JM, Dell'Antonio G, et al:
Pancreatic cancers require autophagy for tumor growth. Genes Dev.
25:717–729. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boya P, Gonzalez-Polo RA, Casares N,
Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D,
Souquere S, Yoshimori T, et al: Inhibition of macroautophagy
triggers apoptosis. Mol Cell Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
El-Khattouti A, Selimovic D, Haikel Y and
Hassan M: Crosstalk between apoptosis and autophagy: Molecular
mechanisms and therapeutic strategies in cancer. J Cell Death.
6:37–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S, Cheng AC, Wang MS and Peng X:
Detection of apoptosis induced by new type gosling viral enteritis
virus in vitro through fluorescein annexin V-FITC/PI double
labeling. World J Gastroenterol. 14:2174–2178. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Budihardjo I, Oliver H, Lutter M, Luo X
and Wang X: Biochemical pathways of caspase activation during
apoptosis. Annu Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Liu X, Bhalla K, Kim CN, Ibrado
AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by
Bcl-2: Release of cytochrome c from mitochondria blocked. Science.
275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Poupel F, Aghaei M, Movahedian A, Jafari
SM and Shahrestanaki MK: Dihydroartemisinin induces apoptosis in
human bladder cancer cell lines through reactive oxygen species,
mitochondrial membrane potential, and cytochrome c pathway. Int J
Prev Med. 8:782017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pankiv S, Clausen TH, Lamark T, Brech A,
Bruun JA, Outzen H, Øvervatn A, Bjørkøy G and Johansen T:
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
ubiquitinated protein aggregates by autophagy. J Biol Chem.
282:24131–24145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SH, Sung JH, Kim EJ and Chung N:
Berberine induces apoptosis via ROS generation in PANC-1 and
MIA-PaCa2 pancreatic cell lines. Braz J Med Biol Res. 48:111–119.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Duong HQ, Hwang JS, Kim HJ, Seong YS and
Bae I: BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest
and apoptosis in human pancreatic cancer cells. Int J Oncol.
41:2227–2236. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Messner MC and Cabot MC: Cytotoxic
responses to N-(4-hydroxyphenyl)retinamide in human pancreatic
cancer cells. Cancer Chemother Pharmacol. 68:477–487. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vaquero EC, Edderkaoui M, Pandol SJ,
Gukovsky I and Gukovskaya AS: Reactive oxygen species produced by
NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J
Biol Chem. 279:34643–34654. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng L, Yan B, Chen K, Jiang Z, Zhou C,
Cao J, Qian W, Li J, Sun L, Ma J, et al: Resveratrol-induced
downregulation of NAF-1 enhances the sensitivity of pancreatic
cancer cells to gemcitabine via the ROS/Nrf2 signaling pathways.
Oxid Med Cell Longev. 2018:94820182018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scherz-Shouval R, Shvets E, Fass E, Shorer
H, Gil L and Elazar Z: Reactive oxygen species are essential for
autophagy and specifically regulate the activity of Atg4. EMBO J.
26:1749–1760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scherz-Shouval R and Elazar Z: ROS,
mitochondria and the regulation of autophagy. Trends Cell Biol.
17:422–427. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Z, Wu F, Yang H and Zhou P:
Endocytosis mechanism of a novel proteoglycan, extracted from
Ganoderma lucidum, in HepG2 cells. Rsc Adv. 7:41779–41786.
2017. View Article : Google Scholar
|
|
38
|
Humpton TJ, Alagesan B, DeNicola GM, Lu D,
Yordanov GN, Leonhardt CS, Yao MA, Alagesan P, Zaatari MN, Park Y,
et al: Oncogenic KRAS induces NIX-mediated mitophagy to promote
pancreatic cancer. Cancer Discov. 9:1268–1287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y and Commisso C: Macropinocytosis
in cancer: A complex signaling network. Trends Cancer. 5:332–334.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Commisso C, Davidson SM, Soydaner-Azeloglu
RG, Parker SJ, Kamphorst JJ, Hackett S, Grabocka E, Nofal M, Drebin
JA, Thompson CB, et al: Macropinocytosis of protein is an amino
acid supply route in Ras-transformed cells. Nature. 497:633–637.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Florey O and Overholtzer M:
Macropinocytosis and autophagy crosstalk in nutrient scavenging.
Philos Trans R Soc Lond B Biol Sci. 374:201801542019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Palm W, Park Y, Wright K, Pavlova NN,
Tuveson DA and Thompson CB: The utilization of extracellular
proteins as nutrients is suppressed by mTORC1. Cell. 162:259–270.
2015. View Article : Google Scholar : PubMed/NCBI
|
